...riseolusthat inhibits protein synthesis. Acts by i...te ribosomes. Reported to induce apoptosis in a va...lls, Jurkat cells, ventricular myocytes, and colon...nals and immediate early gene induction. Selective...
VersArray Hybridization Chamber from Bio-Rad
...ration system using the asymmetric flow Field Flow...rates easily with Wyatts multi-angle light scatter... well as the Optilab DSP. The combined system prov... the particles/molecules separated by the AFFF uni...
Mouse Anti-Fatty Acid Binding Protein (FABP) Antibody, TRITC (Rhodamine) Conjugated from HyTest Ltd.
Biology Products:(Date:11/30/2009)... LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/ ...in Board: CYXN; ,China Yongxin,Pharmaceuticals, or...or and,retailer of pharmaceuticals in Northeastern...on for distribution of medicines on the Essential ...tly formalized the nation,s Essential Drug,List wh...
(Date:11/30/2009)...ewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI...new class of platinum-based anti-tumor compounds, ...i-tumor potency and activity compared to currently... ability to overcome cisplatin-resistance in cance...er titled "Novel Bis-platinum Complexes Endowed wi...
(Date:11/30/2009)... AMSTERDAM, November 30 ...ific, medical and technical products and services,...comprehensive biomedical,database which holds over...ctive, peer reviewed journals. , Embase h...w biomedical,and pharmaceutical insights. Now, new...
(Date:11/27/2009)...ewswire-FirstCall/ -- Stallergenes has been,grante...dults and children,through a Mutual Recognition Pr...R) has been marketed, was the reference Member sta...tria, Belgium, Bulgaria, Cyprus, the,Czech Republi...and, Italy,Latvia, Lithuania, Luxembourg, Malta, ...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3